Torigen Pharmaceuticals is commercializing a revolutionary veterinary cancer treatment. The product, VetiVax, is a personalized cancer treatment for tumor-based cancers, which can be administered the same day as surgery, offering a more convenient and more cost effective way to treat most veterinary cancers. Current state of the art treatments are extremely expensive, while still having uncertain outcomes and often requiring frequent long-distance visits to a specialist veterinary oncologist. Analogous to how Invisalign, the invisible braces, took the dental market by storm, VetiVax offers a cheaper, more convenient and effective treatment to the veterinary space. The VetiVax kit contains all components necessary for any of the 40,000 veterinarians nationwide to create a treatment personalized to the animal's own tumor cells and administer it the same day. It's a stark difference from alternative treatments on the market, including chemo-therapy and radiation therapy.